The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dabigatran Etexilate Mesylate Market Research Report 2025
Synopsis
Dabigatran etexilate is a direct thrombin inhibitor and is the main active principle in plasma. Thrombin enables the conversion of fibrinogen into fibrin during the coagulation cascade. Inhibition of thrombin prevents the development of thrombus. Dabigatran also inhibits free thrombin, fibrin-bound thrombin and thrombin-induced platelet aggregation.
The global Dabigatran Etexilate Mesylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dabigatran Etexilate Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dabigatran Etexilate Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dabigatran Etexilate Mesylate include Polpharma, Apotex Pharmachem, Dr. Reddy’s, Jubilant Pharma, Mehta API, Vasudha Pharma Chem, Tapi Teva, Metrochem and Langfang Gaobo Jingband Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dabigatran Etexilate Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dabigatran Etexilate Mesylate.
Report Scope
The Dabigatran Etexilate Mesylate market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dabigatran Etexilate Mesylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dabigatran Etexilate Mesylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Polpharma
Apotex Pharmachem
Dr. Reddy’s
Jubilant Pharma
Mehta API
Vasudha Pharma Chem
Tapi Teva
Metrochem
Langfang Gaobo Jingband Pharmaceutical
Lee Pharma
Qilu Pharmaceutical
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Dabigatran Etexilate Mesylate Capsule
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dabigatran Etexilate Mesylate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dabigatran Etexilate Mesylate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dabigatran Etexilate Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Dabigatran etexilate is a direct thrombin inhibitor and is the main active principle in plasma. Thrombin enables the conversion of fibrinogen into fibrin during the coagulation cascade. Inhibition of thrombin prevents the development of thrombus. Dabigatran also inhibits free thrombin, fibrin-bound thrombin and thrombin-induced platelet aggregation.
The global Dabigatran Etexilate Mesylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dabigatran Etexilate Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dabigatran Etexilate Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dabigatran Etexilate Mesylate include Polpharma, Apotex Pharmachem, Dr. Reddy’s, Jubilant Pharma, Mehta API, Vasudha Pharma Chem, Tapi Teva, Metrochem and Langfang Gaobo Jingband Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dabigatran Etexilate Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dabigatran Etexilate Mesylate.
Report Scope
The Dabigatran Etexilate Mesylate market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dabigatran Etexilate Mesylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dabigatran Etexilate Mesylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Polpharma
Apotex Pharmachem
Dr. Reddy’s
Jubilant Pharma
Mehta API
Vasudha Pharma Chem
Tapi Teva
Metrochem
Langfang Gaobo Jingband Pharmaceutical
Lee Pharma
Qilu Pharmaceutical
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Dabigatran Etexilate Mesylate Capsule
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dabigatran Etexilate Mesylate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dabigatran Etexilate Mesylate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dabigatran Etexilate Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Dabigatran Etexilate Mesylate Market Overview
1.1 Product Definition
1.2 Dabigatran Etexilate Mesylate Segment by Type
1.2.1 Global Dabigatran Etexilate Mesylate Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Dabigatran Etexilate Mesylate Segment by Application
1.3.1 Global Dabigatran Etexilate Mesylate Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Dabigatran Etexilate Mesylate Capsule
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Dabigatran Etexilate Mesylate Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Dabigatran Etexilate Mesylate Production Estimates and Forecasts (2019-2030)
1.4.4 Global Dabigatran Etexilate Mesylate Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dabigatran Etexilate Mesylate Production Market Share by Manufacturers (2019-2024)
2.2 Global Dabigatran Etexilate Mesylate Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Dabigatran Etexilate Mesylate, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Dabigatran Etexilate Mesylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Dabigatran Etexilate Mesylate Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Dabigatran Etexilate Mesylate, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dabigatran Etexilate Mesylate, Product Offered and Application
2.8 Global Key Manufacturers of Dabigatran Etexilate Mesylate, Date of Enter into This Industry
2.9 Dabigatran Etexilate Mesylate Market Competitive Situation and Trends
2.9.1 Dabigatran Etexilate Mesylate Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dabigatran Etexilate Mesylate Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dabigatran Etexilate Mesylate Production by Region
3.1 Global Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Dabigatran Etexilate Mesylate Production Value by Region (2019-2030)
3.2.1 Global Dabigatran Etexilate Mesylate Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Dabigatran Etexilate Mesylate by Region (2025-2030)
3.3 Global Dabigatran Etexilate Mesylate Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Dabigatran Etexilate Mesylate Production by Region (2019-2030)
3.4.1 Global Dabigatran Etexilate Mesylate Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Dabigatran Etexilate Mesylate by Region (2025-2030)
3.5 Global Dabigatran Etexilate Mesylate Market Price Analysis by Region (2019-2024)
3.6 Global Dabigatran Etexilate Mesylate Production and Value, Year-over-Year Growth
3.6.1 North America Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)
4 Dabigatran Etexilate Mesylate Consumption by Region
4.1 Global Dabigatran Etexilate Mesylate Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Dabigatran Etexilate Mesylate Consumption by Region (2019-2030)
4.2.1 Global Dabigatran Etexilate Mesylate Consumption by Region (2019-2024)
4.2.2 Global Dabigatran Etexilate Mesylate Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Dabigatran Etexilate Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Dabigatran Etexilate Mesylate Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dabigatran Etexilate Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Dabigatran Etexilate Mesylate Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Dabigatran Etexilate Mesylate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Dabigatran Etexilate Mesylate Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dabigatran Etexilate Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Dabigatran Etexilate Mesylate Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Dabigatran Etexilate Mesylate Production by Type (2019-2030)
5.1.1 Global Dabigatran Etexilate Mesylate Production by Type (2019-2024)
5.1.2 Global Dabigatran Etexilate Mesylate Production by Type (2025-2030)
5.1.3 Global Dabigatran Etexilate Mesylate Production Market Share by Type (2019-2030)
5.2 Global Dabigatran Etexilate Mesylate Production Value by Type (2019-2030)
5.2.1 Global Dabigatran Etexilate Mesylate Production Value by Type (2019-2024)
5.2.2 Global Dabigatran Etexilate Mesylate Production Value by Type (2025-2030)
5.2.3 Global Dabigatran Etexilate Mesylate Production Value Market Share by Type (2019-2030)
5.3 Global Dabigatran Etexilate Mesylate Price by Type (2019-2030)
6 Segment by Application
6.1 Global Dabigatran Etexilate Mesylate Production by Application (2019-2030)
6.1.1 Global Dabigatran Etexilate Mesylate Production by Application (2019-2024)
6.1.2 Global Dabigatran Etexilate Mesylate Production by Application (2025-2030)
6.1.3 Global Dabigatran Etexilate Mesylate Production Market Share by Application (2019-2030)
6.2 Global Dabigatran Etexilate Mesylate Production Value by Application (2019-2030)
6.2.1 Global Dabigatran Etexilate Mesylate Production Value by Application (2019-2024)
6.2.2 Global Dabigatran Etexilate Mesylate Production Value by Application (2025-2030)
6.2.3 Global Dabigatran Etexilate Mesylate Production Value Market Share by Application (2019-2030)
6.3 Global Dabigatran Etexilate Mesylate Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Polpharma
7.1.1 Polpharma Dabigatran Etexilate Mesylate Corporation Information
7.1.2 Polpharma Dabigatran Etexilate Mesylate Product Portfolio
7.1.3 Polpharma Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Polpharma Main Business and Markets Served
7.1.5 Polpharma Recent Developments/Updates
7.2 Apotex Pharmachem
7.2.1 Apotex Pharmachem Dabigatran Etexilate Mesylate Corporation Information
7.2.2 Apotex Pharmachem Dabigatran Etexilate Mesylate Product Portfolio
7.2.3 Apotex Pharmachem Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Apotex Pharmachem Main Business and Markets Served
7.2.5 Apotex Pharmachem Recent Developments/Updates
7.3 Dr. Reddy’s
7.3.1 Dr. Reddy’s Dabigatran Etexilate Mesylate Corporation Information
7.3.2 Dr. Reddy’s Dabigatran Etexilate Mesylate Product Portfolio
7.3.3 Dr. Reddy’s Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Dr. Reddy’s Main Business and Markets Served
7.3.5 Dr. Reddy’s Recent Developments/Updates
7.4 Jubilant Pharma
7.4.1 Jubilant Pharma Dabigatran Etexilate Mesylate Corporation Information
7.4.2 Jubilant Pharma Dabigatran Etexilate Mesylate Product Portfolio
7.4.3 Jubilant Pharma Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Jubilant Pharma Main Business and Markets Served
7.4.5 Jubilant Pharma Recent Developments/Updates
7.5 Mehta API
7.5.1 Mehta API Dabigatran Etexilate Mesylate Corporation Information
7.5.2 Mehta API Dabigatran Etexilate Mesylate Product Portfolio
7.5.3 Mehta API Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Mehta API Main Business and Markets Served
7.5.5 Mehta API Recent Developments/Updates
7.6 Vasudha Pharma Chem
7.6.1 Vasudha Pharma Chem Dabigatran Etexilate Mesylate Corporation Information
7.6.2 Vasudha Pharma Chem Dabigatran Etexilate Mesylate Product Portfolio
7.6.3 Vasudha Pharma Chem Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Vasudha Pharma Chem Main Business and Markets Served
7.6.5 Vasudha Pharma Chem Recent Developments/Updates
7.7 Tapi Teva
7.7.1 Tapi Teva Dabigatran Etexilate Mesylate Corporation Information
7.7.2 Tapi Teva Dabigatran Etexilate Mesylate Product Portfolio
7.7.3 Tapi Teva Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Tapi Teva Main Business and Markets Served
7.7.5 Tapi Teva Recent Developments/Updates
7.8 Metrochem
7.8.1 Metrochem Dabigatran Etexilate Mesylate Corporation Information
7.8.2 Metrochem Dabigatran Etexilate Mesylate Product Portfolio
7.8.3 Metrochem Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Metrochem Main Business and Markets Served
7.7.5 Metrochem Recent Developments/Updates
7.9 Langfang Gaobo Jingband Pharmaceutical
7.9.1 Langfang Gaobo Jingband Pharmaceutical Dabigatran Etexilate Mesylate Corporation Information
7.9.2 Langfang Gaobo Jingband Pharmaceutical Dabigatran Etexilate Mesylate Product Portfolio
7.9.3 Langfang Gaobo Jingband Pharmaceutical Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Langfang Gaobo Jingband Pharmaceutical Main Business and Markets Served
7.9.5 Langfang Gaobo Jingband Pharmaceutical Recent Developments/Updates
7.10 Lee Pharma
7.10.1 Lee Pharma Dabigatran Etexilate Mesylate Corporation Information
7.10.2 Lee Pharma Dabigatran Etexilate Mesylate Product Portfolio
7.10.3 Lee Pharma Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Lee Pharma Main Business and Markets Served
7.10.5 Lee Pharma Recent Developments/Updates
7.11 Qilu Pharmaceutical
7.11.1 Qilu Pharmaceutical Dabigatran Etexilate Mesylate Corporation Information
7.11.2 Qilu Pharmaceutical Dabigatran Etexilate Mesylate Product Portfolio
7.11.3 Qilu Pharmaceutical Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Qilu Pharmaceutical Main Business and Markets Served
7.11.5 Qilu Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dabigatran Etexilate Mesylate Industry Chain Analysis
8.2 Dabigatran Etexilate Mesylate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dabigatran Etexilate Mesylate Production Mode & Process
8.4 Dabigatran Etexilate Mesylate Sales and Marketing
8.4.1 Dabigatran Etexilate Mesylate Sales Channels
8.4.2 Dabigatran Etexilate Mesylate Distributors
8.5 Dabigatran Etexilate Mesylate Customers
9 Dabigatran Etexilate Mesylate Market Dynamics
9.1 Dabigatran Etexilate Mesylate Industry Trends
9.2 Dabigatran Etexilate Mesylate Market Drivers
9.3 Dabigatran Etexilate Mesylate Market Challenges
9.4 Dabigatran Etexilate Mesylate Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
